Woodford Investment Management as of March 31, 2017
Portfolio Holdings for Woodford Investment Management
Woodford Investment Management holds 7 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abbvie (ABBV) | 29.4 | $712M | 11M | 65.17 | |
| Prothena (PRTA) | 25.6 | $619M | 11M | 55.76 | |
| Alkermes (ALKS) | 18.1 | $437M | 7.5M | 58.50 | |
| Theravance Biopharma (TBPH) | 16.3 | $394M | 11M | 36.80 | |
| Gilead Sciences (GILD) | 4.5 | $108M | 1.6M | 67.92 | |
| Biogen Idec (BIIB) | 4.3 | $103M | 377k | 273.42 | |
| Bioverativ Inc Com equity | 1.8 | $43M | 791k | 54.44 |
